Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -20,588 | -7,208 | -13,564 |
| Depreciation Amortization | -80 | N/A | 110 |
| Accounts payable and accrued liabilities | 798 | 776 | 31 |
| Other Working Capital | 1,573 | -81 | -1,311 |
| Other Operating Activity | 210 | 689 | 4,191 |
| Operating Cash Flow | $-18,087 | $-5,824 | $-10,543 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -11,889 | N/A | N/A |
| PPE Investments | -109 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,000 |
| Investing Cash Flow | $-11,998 | $N/A | $-1,000 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 332 | N/A | 225 |
| Other Financing Activity | 81,659 | 0 | 0 |
| Financing Cash Flow | $81,991 | $N/A | $225 |
| Beginning Cash Position | 9,735 | 15,559 | 26,877 |
| End Cash Position | 61,641 | 9,735 | 15,559 |
| Net Cash Flow | $51,906 | $-5,824 | $-11,318 |
| Free Cash Flow | |||
| Operating Cash Flow | -18,087 | -5,824 | -10,543 |
| Capital Expenditure | -109 | N/A | N/A |
| Free Cash Flow | -18,196 | -5,824 | -10,543 |